CLINICAL_TRIALS
trial_result
· 2011-02-21
Clinical Trial Update: A Phase II Study of CC-5013 in Myelofibrosis [Phase 2]
Summary
Phase II study of CC-5013 in myelofibrosis has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Myelofibrosis | Phase 2 | Status: COMPLETED | Results posted: 2011-02-21